Locomotor and discriminative stimulus effects of NBOH hallucinogens in rodents.
Daaniyal D. Munir, Ritu A. Shetty, Michael B. Gatch, Nathalie Sumien, Rebecca D. Hill, Jeanne A. Priddy, Michael J. Forster
Behavioural Pharmacology December 6, 2024 DOI: 10.1097/fbp.0000000000000802 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical study Peer reviewed |
|---|---|
| Population | Mice and rats |
| Interventions | 25B-NBOH 25C-NBOH 25E-NBOH 25I-NBOH |
| Keywords | Nbohs Emerging compounds Novel psychoactive substances Synthetic hallucinogens Psychoactive effects Perception-altering drugs Psychedelics Psychotomimetics Brain pathways Neuropharmacology Psychopharmacology Animal models Rodent studies Preclinical research Drug discrimination Behavioral pharmacology |
| Citations | 1 |
| Key points | Three of four NBOH compounds fully substituted for the hallucinogen DOM in rats, suggesting they are likely to be used as recreational hallucinogens, while 25I-NBOH did not fully substitute and may have lower abuse liability. |
Abstract
Despite the efforts of the Drug Enforcement Administration to safeguard the public from hazardous analogs of synthetic hallucinogens, these compounds have increasingly been observed in the illicit drug market. Four novel compounds were found to be similar in structure to the previously described 25X-NBOMe synthetic hallucinogens. These four compounds, 25B-NBOH, 25C-NBOH, 25E-NBOH, and 25I-NBOH were evaluated for their ability to modify spontaneous locomotor activity in mice to obtain dose range and time-course information and were then tested for discriminative stimulus effects similar to the prototypical hallucinogen (-)-2,5-dimethoxy-4-methylamphetamine (DOM). All four test compounds decreased locomotor activity. The locomotor depressant effects were similar in magnitude and potency to DOM, but less potent than the 25X-NBOMe compounds in previous reports. 25B-NBOH, 25C-NBOH, and 25E-NBOH fully substituted (≥80%) in DOM-trained rats, whereas 25I-NBOH failed to fully substitute for DOM even at doses that suppressed responding. The discriminative stimulus effects were more potent than those of DOM and the 25X-NBOMe compounds. These findings suggest that three of the four test compounds are most likely to be used as recreational hallucinogens in a similar manner to DOM and the 25X-NBOMe compounds, whereas 25I-NBOH may be less liable to illicit use.
Citations in the library
Cites 17
- Neuropharmacology of N,N-dimethyltryptamine Brain Research Bulletin April 30, 2016
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology December 1, 2015
- Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chemical Neuroscience March 19, 2014
- Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology March 1, 2014
- Characterization of the Discriminative Stimulus Properties Induced by 5‐HT1and 5‐HT2Agonists in Rats Pharmacology & Toxicology February 1, 1989
and 12 more in the library